David Goel
David Goel's Matrix Capital Management holds 1 U.S.-equity positions worth $46M (SEC 13F, Q1 2026). Top positions: Aura Biosciences, Inc. Common Stock 100.0%. 13F-replication return is +246% over 3 years (+174 pts vs the S&P 500) — a replicated, non-audited figure.
Holdings
| Stock | % of portfolio | Shares | Value | Latest activity | Avg buy price | Current price | Date |
|---|---|---|---|---|---|---|---|
| AURA Aura Biosciences, Inc. Common Stock | 100.0% | 6.9M | $46M | — | $9.28 | $6.95 (−25%) | 2026-03-31 |
Related ▾
FAQ ▾
What are David Goel's largest holdings?
As of the latest 13F: Aura Biosciences, Inc. Common Stock 100.0%.
How big is Matrix Capital Management's 13F portfolio?
$46M across 1 disclosed U.S.-equity positions.
What is David Goel's 3-year performance?
+246% (13F-replication, price return), +174 pts vs the S&P 500. Not an audited fund return.
Where does this data come from?
U.S. SEC Form 13F-HR institutional holdings filings.
Sourced from SEC Form 13F-HR filings · Not investment advice ▾
Latest activity = change vs. the prior 13F. Avg buy price = est. entry over the trailing 3 years (gain = vs. latest price). Returns are 13F-replication, not audited fund returns. Sourced from SEC 13F filings.